Clinical Trials Logo

Celiac clinical trials

View clinical trials related to Celiac.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04240340 Completed - Celiac Disease Clinical Trials

Experiences of Disclosure in Adolescents With Coeliac Disease

Start date: March 1, 2020
Phase:
Study type: Observational

Being diagnosed with coeliac disease means that individuals can no longer consume things containing gluten, such as bread or cake, or they can become very ill. This can make situations involving food challenging, such as social situations or lunch at school. The investigators know that being diagnosed with coeliac disease as a teenager can be particularly upsetting and can lead to problems such as anxiety or low mood. Research suggests that when young people are worried about the impact of their condition on their life, they can find it challenging to tell their doctor or ask for support. The investigators would like to understand the experiences of young people with coeliac disease who attend the Paediatric Gastroenterology service at a local children's hospital. The investigators are particularly interested in the reasons why young people either feel able or unable to tell their doctor that they are experiencing difficulties relating to their wellbeing during their appointments, in order to improve support for young people. This study aims to recruit young people between the ages of 11 and 16, who are attending secondary school, to ask them about the things that make it easier or more difficult to share any concerns about their wellbeing with their doctor.

NCT ID: NCT03122093 Completed - Clinical trials for Diabetes Mellitus, Type 1

Celiac Disease and Diabetes Longitudinal Follow-up and Evaluation Study

CD-LiFE
Start date: May 1, 2017
Phase:
Study type: Observational

To the investigators' knowledge, no single long-term prospective observational study has assessed dietary factors, diabetes clinical variables (metabolic control and associated complications), and self -perceived health and wellness in T1D patients (both pediatric and adult) with CD identified by screening (positive/weakly positive serology). The aim of the current study is to observe the short- and long-term outcomes for Type 1 diabetic patients with new serology positive asymptomatic CD.